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Abstract
Background: The present study investigated the antibacterial activity and underlying mechanisms of ginkgolic acid
(GA) C15:1 monomer using green fluorescent protein (GFP)-labeled bacteria strains.
Results: GA presented significant antibacterial activity against Gram-positive bacteria but generally did not affect
the growth of Gram-negative bacteria. The studies of the antibacterial mechanism indicated that large amounts of
GA (C15:1) could penetrate GFP-labeled Bacillus amyloliquefaciens in a short period of time, and as a result, led to
the quenching of GFP in bacteria. In vitro results demonstrated that GA (C15:1) could inhibit the activity of multiple
proteins including DNA polymerase. In vivo results showed that GA (C15:1) could significantly inhibit the biosynthesis
of DNA, RNA and B. amyloliquefaciens proteins.
Conclusion: We speculated that GA (C15:1) achieved its antibacterial effect through inhibiting the protein activity of B.
amyloliquefaciens. GA (C15:1) could not penetrate Gram-negative bacteria in large amounts, and the lipid soluble
components in the bacterial cell wall could intercept GA (C15:1), which was one of the primary reasons that GA
(C15:1) did not have a significant antibacterial effect on Gram-negative bacteria.
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Background
Plants can synthesize over 200,000 compounds through
various metabolic pathways [1]. Secondary metabolites in
plants are derived from primary metabolites, and their
categories and chemical structures are complex and di-
verse, including nitrogen-containing organic compounds,
terpenoids, phenols and polyacetylenes, of which alkaloids,
terpenoids and phenols are the most common. Secondary
metabolites are widely involved in plant growth, develop-
ment and defense as well as other physiological and bio-
logical processes [2]. Plant secondary metabolites provide
many useful natural organic compounds for human use.
Because traditional chemical pesticides contaminate soil
and water, the development of environmentally friendly
bio-pesticides has become a popular research focus. How-
ever, the development of synthetic pesticides has many
problems, such as a low successful rate, long cycle and
huge cost etc. Therefore, discovering lead compounds
(plant-derived antibacterial reagents) from natural plant
products with improved biological activity has become an
effective method to develop new biological pesticides.
Self-defense mechanisms have been evolved in plants, and
many secondary plant metabolites are natural antibacterial
agents [3–5]. Wilkins et al. [6] reported that 1389 plants
could be used as sources of plant antibacterial agents in-
cluding ingredients that could kill or inhibit bacteria, such
as antibiotics, flavonoids, organic acids, polyphenols and
specific proteins. Wilson et al. [7] studied the inhibition of
Botrytis cinerea by 345 crude plant extracts and 49 essen-
tial oils, found that 13 crude extracts and 4 essential oils
provided antibacterial activities.
Resorcinolic lipids are widely distributed plant secondary
metabolites produced in large numbers. Recent studies
have shown that they have extraordinarily high antibacterial
activity. Resorcinolic lipids produced by Pseudomonas car-
boxydoflava can inhibit the growth of many bacteria spe-
cies, such as Micrococcus lysodeictius and Bacillus subtilis
[8, 9]. Resorcinolic lipids isolated from cashew apple have
strong antibacterial effects on Gram-positive bacteria,
including methicillin-resistant S. aureus strains [10, 11].
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Sixteen phenolic compounds have been isolated from the
cashew Anacardium occidentale (Anacardiaceae) nut shell
oil, including various C15 phenolic compounds. Their anti-
microbial activity has been tested against four typical mi-
croorganisms, Bacillus subtilis, a Gram-positive bacterium;
Escherichia coli, a Gram-negative bacterium; Saccharomy-
ces cereuisiae, a yeast; and Penicillium chrysogenum, a mold.
Most of them exhibited potent antibacterial activity against
only Gram-positive bacteria [12].
Ginkgo is a Chinese-specific rare relict species that is
well known as a “living fossil of gymnosperms” [13]. The
fruit and leaves of ginkgo have relatively high economic
and medicinal values. However, its sarcotestas is usually
discarded, causing secondary pollution of the environ-
ment [14]. GA, which is in high level in sarcotestas, is a
natural plant-derived active substance contained in ginkgo,
and it belongs to long-chain phenolic compounds that are
derivatives of sumac acid [15]. Current studies have shown
that the biological activities of GA include anti-tumor
activity, neuroprotective activity, anxiolytic and anti-
bacterial activity [16–20]. These biological activities
may make a possibility that increases the utilization of
ginkgo sarcotestas and reduces environmental pollu-
tion. The potential uses of Ginkgo have been attracted
many concern. Studies of GA antibacterial activity
have found that although GA could inhibit the activity
of bacteria and plant pathogens, it just showed selective
antibacterial activity, with strong inhibition towards to
Gram-positive bacteria and almost no inhibition to Gram-
negative bacteria [21–24].
The present study employed GFP-labeled strains and
analyzed the antibacterial activity and mechanisms of
GA C15:1 monomer, high amounts of which was in
ginkgo sarcotestas and had relatively high antibacterial
activity. Investigations of the selective antibacterial ac-
tivity of GA could provide a scientific and theoretical
basis for the development of new plant-derived pesti-
cides using ginkgo sarcotestas as the raw material.
Results
Antibacterial activity of GA (C15: 1)
The antibacterial activity of GA (C15:1) is shown in
Table 1. GA (C15:1) had strong antibacterial activity
against Gram-positive bacteria, the MIC values of all of
the tested Gram-positive bacteria were not greater than
10 μg mL−1..In this study, all of the tested Gram-negative
bacteria could grow well after the addition of large doses
of GA (C15:1) (final concentration 500 μg mL−1), and no
differences were observed compared with the controls
supplemented with salicylic acid, indicating that GA
(C15:1) did not have significant antibacterial action against
Gram-negative bacteria.
The effect of GA (C15:1) on GFP in bacteria
Using a GFP-labeled strain as the target, we studied effect
of GA (C15:1) on GFP fluorescence in bacteria, and the
results are show in Fig. 1-a). GA (C15:1) could signifi-
cantly affect GFP fluorescence in the Gram-positive
bacteria B. amyloliquefaciens SQR9-gfp within 1 min.
Compared with the results for the CK (bacteria only con-
taining DMSO), GA (C15:1) at the concentration of
5 μg mL−1 could reduce GFP fluorescence intensity in
SQR9 bacteria by more than 50% within 1 min, and GA
(C15:1) at higher concentrations could almost completely
quench GFP fluorescence in SQR9 bacteria within 1 min.
Although GA (C15:1) could significantly affect GFP
fluorescence in B. amyloliquefaciens SQR9-gfp bacteria
within 1 min, it did not have a significant effect on GFP
fluorescence in Gram-negative bacteria E. coli DH5α-gfp
and P. putida KT2440-gfp. Within 1 min, a significant
decrease of fluorescence intensity was not detected in
the studied Gram-negative bacteria, and fluorescence
intensity values in the CK were close to the fluorescence
intensity value in bacteria supplemented with GA.
We extended the contact time of Gram-negative bac-
teria E. coli DH5α-gfp and P. putida KT2440-gfp with
GA (C15:1) to 4 h. The results (Fig. 1-b) showed that
Table 1 Antibacterial activities of GA (C15:1) and salicylic acid
Strains Control GA (C15:1) Salicylic acid
MIC (μg mL−1) MBC (μg mL−1) MBC (μg mL−1) MBC (μg mL−1) MIC (μg mL−1) MBC (μg mL−1)
G− E. coli DH5α >500 - >500 - >500 -
E. coli O157:H7 >500 - >500 - >500 -
P. putida KT2440 >500 - >500 - >500 -
P. aeruginosa PAO1 >500 - >500 - >500 -
R. solanacearum >500 - >500 - >500 -
G+ B. amyloliquefaciens SQR9 >500 - 5 60 500 >500
R. jostii RHA1 >500 - 10 20 500 >500
S. thermophilus ND03 >500 - 10 20 500 >500
S. aureus >500 - 10 20 500 >500
- Not measured, GA ginkgolic acid, MIC the minimum inhibitory concentration, MBC the minimum bactericidal concentration
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even with longer incubation times, GA could only reduce
GFP fluorescence in Gram-negative bacteria by a small
amount. GA (C15:1) at the concentration of 500 μg mL−1
had the most significant effect on fluorescence in E. coli
DH5α-gfp, causing approximately 30% fluorescence re-
duction. The fluorescence reduction values at other con-
centrations were all less than 25%.
The scanning electron microscopy examination
showed that after the addition of GA (C15:1), the cells
of the three bacteria still remained intact without
apparent cell lysis (Fig. 2). Because GFP protein was
only present in the bacteria, we speculated that GFP
fluorescence decay in Gram-positive bacteria B. amy-
loliquefaciens SQR9-gfp was caused by a large amount
of GA that entered the bacteria within a short time,
whereas the reason that GFP fluorescence in both
Gram-negative bacteria did not show decay was that
GA (C15:1) did not enter these bacteria in a large
amount. The lack of a significant reduction in GFP
fluorescence in the two Gram-negative bacteria was
caused by a limited amount of GA entering the cells.
Effect of GA (C15:1) on GFP in bacteria crude extracts
To verify the hypothesis that “GFP fluorescence decay was
related to GA entering the bacteria cells”, the bacteria cells
of Gram-negative bacteria E. coli DH5α-gfp and P. putida
KT2440-gfp were lysed and centrifuged, and the crude
lysate supernatants which contained GFP, were collected.
GA (C15:1) was directly added to the supernatant, and the
GFP fluorescence intensity was examined. The same pro-
cedure was performed on Gram-positive bacteria B. amylo-
liquefaciens SQR9-gfp. The results showed that GA (C15:1)
could significantly affect GFP fluorescence in the crude
lysates of E. coli DH5α-gfp and P. putida KT2440-gfp
within 1 min (Fig. 3). Compared with the results for the
CK, GA (C15:1) at a final concentration > 25 μg mL−1 could
completely quench GFP fluorescence in the crude lysates of
E. coli DH5α-gfp and P. putida KT2440-gfp within 1 min.
Fig. 1 Effect of GA (C15:1) on GFP fluorescence in bacteria. Three independent experiments were conducted (n = 3); the error bars indicate one
standard error. Three individual tubes were collected from LB plates, and each tube was performed in triplicate. Each bar in the gram represents
means of three individual tubes (mean + − non-log transfoemed SE.). a: Bacteria were incubated at 30 °C for 1 min before GFP fluorescence was
measured.10 μL of DMSO without the drug was used as a control. The blank was the E. coli bacteria solution without GFP. One-way ANOVA was
used for analyzing the data (F7,16 = 656.9 P < 0.001(SQR9-gfp); F7,16 = 0.208 P > 0.05(DH5α-gfp); F7,16 = 0.357 P > 0.05 (KT2440-gfp)); (b) Bacteria were
incubated at 30 °C for 4 h before GFP fluorescence was measured. 10 μL of DMSO without the drug was used as a control. The blank was the E. coli
bacteria solution without GFP. One-way ANOVA was used for analyzing the data (F7,16 = 0.178 P > 0.05(DH5α-gfp); F7,16 = 1.412 P > 0.05 (KT2440-gfp))
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Similar fluorescence decay results were also showed in
the crude cell lysates of Gram-positive bacteria B. amy-
loliquefaciens SQR9-gfp (Fig. 3). When the concentra-
tion of GA (C15:1) was > > 10 μg mL−1, the fluorescence
in the crude lysates of B. amyloliquefaciens SQR9-gfp
was completely quenched within 1 min. This results
were consistent with the results of the GFP fluorescence
decay experiment in B. amyloliquefaciens SQR9-gfp
cells, and suggested that GA could enter the cells of
Gram-positive bacteria B. amyloliquefaciens SQR9-gfp
GFP within a short period of time.
Effect of GA on the activity of a variety of proteins
According to the PCR results (Fig. 4-a), GA (C15:1)
significantly inhibited the PCR reaction. The addition of
1 μg mL−1 and 5 μg mL−1 GA (C15:1) could interfere
with PCR reactions, resulting in decreased specific
bands, although these concentrations would not com-
pletely inhibit PCR reactions. However, when the
concentration of GA was ≥ 10 μg mL−1, the PCR reac-
tion was completely inhibited, and electrophoresis could
not detect specific target bands. This result suggested
that lower concentration of GA (C15:1) could inhibit
Taq DNA polymerase activity and interfere with DNA
replication.
Restriction digestion electrophoresis results showed that
GA (C15:1) could significantly inhibit the enzymatic activity
of Kpn I, Hind III and EcoR I (Fig. 4-b, c, d). GA (C15:1) at
a final concentration of 1 μg mL−1 could partially inhibit
the enzymatic activity of the three restriction enzymes.
When the concentration of GA (C15:1) was > 5 μg mL−1,
the enzymatic activity of the three restriction enzymes were
inhibited almost completely, and the super coiled pUC19
plasmid was barely digested.
GA (C15:1) could significantly inhibit SOD enzyme ac-
tivity and β-galactosidase activity (Fig. 5-a, b). When the
final concentration of GA (C15:1) was 1 μg mL−1, both
SOD enzyme activity and β-galactosidase activity were
decreased by 50% compared with that of the control.
When the final concentration of GA was > 5 μg mL−1,
Fig. 2 SEM observation of bacteria cell morphology. respectively, (a, b, c) represent Bacteria cell morphology before the addition of GA; (d, e, f)
represent Bacteria cell morphology after the addition of GA at a final concentration of 100 μg mL−1 for 1 min
Fig. 3 Effect of GA (C15:1) on GFP fluorescence in bacteria crude lysates
(1 min). Three independent experiments were conducted (n= 3). The
error bars indicate one standard error. All of the tests were incubated at
30 °C for 1 min before GFP fluorescence was measured. 10 μL of DMSO
without the drug was used as a control. The blank was the E. coli
bacteria solution without GFP. One-way ANOVA was used for analyzing
the data (F7,16 = 281.4 P < 0.001 (SQR9-gfp); F7,16 = 246.3 P < 0.001
(DH5α-gfp); F7,16 = 304.0 P < 0.001 (KT2440-gfp)). Three individual
tubes were collected from LB plates, and each tube was performed in
triplicate. Each bar in the gram represents means of three individual
tubes (mean + − non-log transfoemed SE.)
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SOD enzyme activity and β-galactosidase enzyme ac-
tivity were almost undetectable.
These proteins had different sources and were selected
randomly. Thus, the results of this study suggested that
the inhibition of GA (C15:1) on protein activities was
non-selective.
Inhibition of isotope incorporation experiments
The aforementioned experiments showed that GA could
inhibit DNA polymerase function in vitro. However, it
was unclear whether GA had a similar function in bac-
teria, including whether GA (C15:1) could inhibit DNA
polymerase activity in vivo, which would inhibit DNA
replication. In addition, it is unclear whether GA could
inhibit RNA polymerase and ribosome activities, which
would inhibit transcription and translation. To further
clarify the mechanism of GA (C15:1), we used the
method of the inhibition of isotope incorporation to verify
the effects of GA (C15:1) in vivo. (Methy-3H) thymine
([3H] TdR), 3H-uridine ([3H] UR) and 3H-tyrosine ([3H]
Tyr) were used as precursors to determine effect of GA
(C15:1) on the biosynthesis of DNA, RNA and B. amyloli-
quefaciens SQR9 proteins. The results are showed in Fig. 6.
Compared with that of the control, GA (C15:1) could
inhibit DNA replication, RNA synthesis and protein syn-
thesis to different extents under all three concentrations
(25 μg mL−1, 10 μg mL−1 and 5 μg mL−1). When the con-
centration of GA (C15:1) reached 25 μg mL−1, the inhib-
ition of [3H] TdR incorporation was approximately 99%,
of [3H] UR incorporation was approximately 90%, and of
protein precursor [3H] tyrosine was approximately 85%.
These data indicated that GA (C15:1) could inhibit DNA
replication in vivo as well as RNA transcription and
protein synthesis.
The interception of GA by Gram-negative bacteria cell
walls
Using E. coli as the target, lysozyme was used to destroy
the peptidoglycan structure in the cell wall and thus E. coli
DH5α-gfp protoplasts were obtained. Effect of GA (C15:1)
Fig. 4 Effect of GA (C15:1) on a variety of proteins. respectively :(a) represents the effect of GA (C15:1) on the activity of Taq DNA Polymerase. The
DNA contration at the bottom of fig represents the PCR reaction was inhibited by GA (C15:1). b represents the effect of GA (C15:1) on the activity
of Kpn I. The DNA contration at the bottom of fig represents the enzymatic activity Kpn I was inhibited by GA (C15:1) (c) represents the effect of
GA (C15:1) on the activity of Hind III. The DNA contration at the bottom of fig represents the enzymatic activity Hind III was inhibited by GA
(C15:1) (d) represents the effect of GA (C15:1) on the activity of EcoR I. The DNA contration at the bottom of fig represents the enzymatic activity
EcoR I was inhibited by GA (C15:1) lane 1, CK; lane 2, addition of DMSO into PCR or digestion system; lane 3, addition of 1 μg mL−1 GA (C15:1)
into PCR or digestion system; lane 4, addition of 5 μg mL−1 GA (C15:1) into PCR or digestion system; lane 5, addition of 10 μg mL−1 GA (C15:1)
into PCR or digestion system; lane 6, addition of 25 μg mL−1 GA (C15:1) into PCR or digestion system; lane 7, addition of 50 μg mL−1 GA (C15:1)
into PCR or digestion system
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on GFP fluorescence in the protoplast within 1 minute
was measured. The results (Fig. 7) showed that when the
final concentration of C15:1 was lower than 25 μg mL−1, it
did not have significant effect on GFP fluorescence in pro-
toplasts. When the final concentration of GA was ≥
25 μg mL−1, the decreased GFP fluorescence intensity in
the protoplasts was found. It was positively correlated
with increasing concentration of GA. When the final
concentration of GA reached 500 μg mL−1, the GFP fluor-
escence intensity in the protoplasts decreased to approxi-
mately 80% of the control. This result suggested that after
the peptidoglycan structure in the Gram-negative bacteria
cell wall was destroyed, a small amount of high concentra-
tion GA could enter the Gram-negative bacteria cell and
produce a low level of GFP fluorescence decay.
By soaking E. coli cells in ethanol solution for a short
period of time, the lipid-soluble components (mainly
included lipopolysaccharide and phospholipids) in the
cell wall were removed/partially removed. Effect of GA
(C15:1) on GFP fluorescence in the E. coli cells that did
not have lipid-soluble components in their cell walls,
was measured. The results (Fig. 8) showed that when the
final concentration of GA reaches was 5 μg mL−1, a large
degree decrease of GFP fluorescence in E. coli occurred.
When the final concentration of GA was above
Fig. 5 Effect of GA (C15:1) on the activity of SOD and β-galactosidase.
The error bars indicate one standard error. a: Effect of GA (C15:1) on the
activity of SOD.The optical density (OD)560 values were measured. 5 μL of
DMSO (without the drug) was used as a control. One-way ANOVA was
used for analyzing the data (F5,12 = 161.6 P < 0.001);(b) : Effect of GA
(C15:1) on the activity of β-galactosidase. The OD value at 420 nm was
read. 5 μL of DMSO (without the drug) was used as a control. One-way
ANOVA was used for analyzing the data (F5,12 = 25.15 P < 0.001). Three
individual tubes were collected from LB plates, and each tube was
performed in triplicate. Each bar in the gram represents means of three
individual tubes (mean + − non-log transfoemed SE.)
Fig. 6 Effect of GA (C15:1) on the incorporation of precursors for the
synthesis of macromolecules in B. amyloliquefaciens SQR9. The error
bars indicate one standard error. The final concentrations of GA in
the reaction system were 25 μg mL−1, 10 μg mL−1 and 5 μg mL−1,
respectively. 5 μL of DMSO (without the drug) was used as a control.
All of the treatments were conducted at 37 °C in a shaker. One-way
ANOVA was used for analyzing the data (F2,6 = 8.72 P = 0.017 (TdR);
F2,6 = 19.54 P = 0.002 (UR); F2,6 = 28.59 P < 0.001 (Tyr)). Three individual
tubes were collected from LB plates, and each tube was performed in
triplicate. Each bar in the gram represents means of three individual
tubes (mean + − non-log transfoemed SE.)
Fig. 7 Effect of GA (C15: 1) on GFP fluorescence in the protoplasts
of E. coli DH5α-gfp (1 min). Three independent experiments were
conducted (n = 3); The error bars indicate one standard error. 5 μL of
DMSO (without the drug) was used as a control. The blank was E.
coli protoplast solution without GFP. All the tests were incubated at
30 °C for 1 min. One-way ANOVA was used for analyzing the data
(F7,16 = 0.106 P > 0.05 (DH5α-gfp); F7,16 = 1.412 P > 0.05 (KT2440-gfp)).
Three individual tubes were collected from LB plates, and each tube
was performed in triplicate. Each bar in the gram represents means
of three individual tubes (mean + − non-log transfoemed SE.)
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10 μg mL−1, it could completely quench the GFP fluor-
escence in E. coli. However, if the lipid-soluble compo-
nents were not removed from the E. coli bacteria cell
wall, even the final concentration of GA at 500 μg mL−1
could not quench the GFP fluorescence (Fig. 1-a). These
results showed that the lipid-soluble components in
Gram-negative bacteria cell walls could intercept GA.
Discussion
In this study, E. coli DH5α, E. coli O157: H7, P. putida
KT2440, P. aeruginosa PAO1, R. solanacearum, Rho-
dococcus RHA1, S. thermophilus ND03, S. aureus and
other common strains were used to study the antibacterial
activity of GA (C15:1), and GA was found to have signifi-
cant antibacterial activity against Gram-positive bacteria
but little effect on the growth of Gram-negative bacteria.
A relatively strong selective antibacterial mechanism of
GA was observed. The MIC value of B. amyloliquefaciens
SQR9 was the smallest among all of the tested Gram-
positive bacteria. However, its MBC value (60 μg mL−1)
was the largest among all of the tested Gram-positive
bacteria. These results might be caused by small amount
of endospores that were generated when B. amyloliquefa-
ciens SQR9 was cultured. Endospores had relatively strong
resistance, and could withstand higher concentrations of
GA without being killed. Therefore, B. amyloliquefaciens
SQR9 had significantly higher MBC values than other
Gram-positive bacteria. The antibacterial activity of GA
has been reported these years. Himejima and Kubo [12]
found that 2-hydroxy-6-(8-pentadecenyl) salicylic (another
name of ginkgolic acid C15:1) showed lower MICs (about
10 μg mL−1) against Gram-positive bacteria and higher
MICs (>100 μg mL−1) against Gram-negative bacteria.
Choi et al. [23] also showed that GA (C15:1) had significant
antibacterial activity against 18 g-positive vancomycin-
resistant. The results of the present study are consistent
with above studies.
Additional studies on antibacterial mechanisms using
GFP fluorescence-labeled Gram-positive bacteria B.
amyloliquefaciens SQR9 and GFP-labeled Gram-negative
bacteria E. coli DH5α and P. putida KT2440 showed that
GA (C15:1) could significantly affect GFP fluorescence
in the cells of Gram-positive B. amyloliquefaciens SQR9-
gfp, whereas it had no significant effect on GFP fluores-
cence in the cells of Gram-negative bacteria E. coli DH5α-
gfp and P. putida KT2440-gfp. The green fluorescent pro-
tein (GFP) has been widely used as a highly useful tool in
the fluorescence studies of living cells, which is found in
cell cytoplasm of jellyfish and is an extremely stable
protein with 238 amino acids [25, 26]. The fluorescence
produced by GFP was caused by its protein conformation.
In general, as long as the protein conformation of GFP did
not change, the fluorescence would not decay or disappear.
Previous reports showed that GA and sumac acids, which
had a similar structure, could affect the activity of
numerous enzymes, including protein phosphatase,
lipoxygenase and histone acetyltransferase [27–29]. In
addition, GA affected in vivo regulation mechanism of
small ubiquitin-related modifier (SUMO) and altered
protein conformation, thereby affecting protein expres-
sion [30].
According to the above test, we suggested that the
mechanism by which GA (C15:1) decayed GFP fluores-
cence was through conformation changes in the GFP
protein. In addition, the mechanism by which GA pro-
moted antibacterial activity against Gram-positive bacteria
was through conformational changes of the proteins in
the bacteria that inactivated the proteins and inhibited the
growth of Gram-positive bacteria.
The results of crude cell lysate experiments showed that
GFP fluorescence decay might be related to the interaction
between GFP and GA. The GFP fluorescence in both
Gram-negative and Gram-positive bacteria crude lysates
was quenched by GA in a short period of time, which indi-
cated that GFP fluorescence would be quenched as long as
it had contact with GA and was not related to the micro-
organism tagged with GFP. Because the structure between
Gram-negative and Gram-positive bacteria was similar and
results showed that peptidoglycan in Gram-positive bac-
teria could not prevent GA (C15:1) from entering the cell,
we suggested that the peptidoglycan structure of Gram-
negative bacteria also could not block GA (C15:1) from
entering the cell. In the protoplast experiment, a small
Fig. 8 Effect of GA (C15: 1) on GFP fluorescence in E. coli DH5α-gfp
(1 min), in which the lipids have been removed from the strains’ cell
wall. Three independent experiments were conducted (n = 3). The
error bars indicate one standard error. 5 μL of DMSO (without the
drug) was used as a control. The blank was E. coli bacteria solution
without GFP (after ethanol solubilization). All the tests were incubated at
30 °C for 1 min. One-way ANOVA was used for analyzing the data (F7,16
= 2.116 P> 0.05 (Black); F7,16 = 121.6 P< 0.001 (White)). Three individual
tubes were collected from LB plates, and each tube was performed in
triplicate. Each bar in the gram represents means of three individual
tubes (mean +− non-log transfoemed SE.)
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amount of GA molecules could enter the cells after the
peptidoglycan structure in E. coli cell wall was destroyed by
lysozyme, which might be the result of the action of lyso-
zyme. After the peptidoglycan structure was destroyed by
lysozyme, pores might be present on the surface of the
peptidoglycan layer that allowed GA molecules to pass
through. However, only a small amount of GA molecules
could enter the cells because the number of pores
generated on the surface of the peptidoglycan layer was
low, and the surface of Gram-negative bacteria was still
covered by a large amount of lipids (including lipopoly-
saccharides and phospholipids), which could intercept a
large amount of GA molecules. In order to further
confirm lipid-soluble components in the cell wall of
Gram-negative bacteria intercept the majority of GA
molecules, the studies use high resolution electron
microscopy to observe membrane change or other
methods to study transport of GA through membrane
will be carried out.
Some studies demonstrated that GA markedly inhibited
the biofilm formation of S. mutans and Escherichia coli
O157:H7, and disrupted biofilm integrity [24, 31]. There-
fore, we speculate that the GA may affect the secondary
metabolism of Gram-positive and Gram-negative bacteria.
Due to the secondary metabolism of bacteria, such as the
formation of biofilm, fluorescence formation and synthesis
of antibiotics are regulated by quorum-sensing, further
studies on this section will be investigated.
Conclusions
GA (C15:1) has a relatively strong selective antibacterial
mechanism, which significant antibacterial activity against
Gram-positive bacteria but little effect on the growth of
Gram-negative bacteria. Additional studies on antibacterial
mechanisms showed that GA (C15:1) could inhibit the
activities of the selected proteins to a certain degree, and
non-selectively induce protein conformational changes. GA
(C15:1) also inhibit DNA replication in vivo as well as RNA
transcription and protein synthesis. Thus, we suggested that
the mechanism by which GA (C15:1) promoted antibacter-
ial activity against Gram-positive bacteria was through
conformational changes of the proteins in the bacteria that
inactivated the proteins and inhibited the growth of Gram-
positive bacteria. The research results indicated that lipid-
soluble components (including lipopolysaccharide and
phospholipids) in the cell wall of Gram-negative bacteria
intercepted the majority of GA molecules, whereas the pep-
tidoglycan layer in the cell wall showed a reduced capacity
to intercept GA molecules.
Methods
Media and reagents
Lysogeny broth (LB) medium (g L−1) was composed as
follows: peptone 10.0 g L−1, yeast extract 5.0 g L−1, NaCl
10.0 g L−1, pH 7.2, (solid, addition of 1.5% agar), and de-
ionized water 1000 mL, which was sterilized at 121 °C
for 20 min.
Proteinase K, lysozyme, ampicillin (Amp), kanamycin
(Km), gentamicin (Gm), isopropyl-β-D-thiogalactopyrano-
side (IPTG), o-nitrophenyl β-D-galactopyranoside (ONPG),
and o-nitrophenol (ONP) were purchased from Shanghai
Sangon Biotech (Sangon Biotech, Shanghai, China). GA
C15:1 standard was purchased from Shanghai Tauto
Biotechnology (Shanghai, China). Other chemical reagents
were analytical grade.
Strains
Escherichia coli DH5α (E. coli DH5α) (ATCC53338), E. coli
O157: H7 (E. coli O157: H7) (ATCC43895), Pseudomonas
putida KT2440 (ATTC47054), Pseudomonas aeruginosa
PAO1 (ATCC15692), Ralstoniasolanacearum (ATCC11
696), Rhodococcusjostii RHA1 [32], Streptococcus thermo-
philus ND03 [33], and S. aureus (ATCC25923) were from
our laboratory.
Bacillus amyloliquefaciens SQR9 (CGMCC 5808;
China General Microbiology Culture Collection Center)
[34], E. coli-gfp (E. coli DH5α-gfp), P. putida KT2440-
gfp, and B. amyloliquefaciens SQR9-gfp were provided
by the Environmental Microbiology Lab at the College
of Resources and Environment, Nanjing Agricultural
University.
Determination of antibacterial activity of GA
A conventional broth-dilution method was adopted
[35]. GA and salicylic acid were dissolved into
dimethylsulfoxide (DMSO) to prepare stock solutions
with different concentrations, respectively. The final
concentrations of the drug (GA or salicylic acid) in
the medium (500 μg mL−1, 250 μg mL−1, 100 μg mL
−1, 80 μg mL−1, 60 μg mL−1, 40 μg mL−1, 20 μg mL
−1, 10 μg mL−1, 5 μg mL−1, 2 μg mL−1, 1 μg mL−1,
0.5 μg mL−1 and 0.1 μg mL−1) were obtained. 10 μL
stock solutions were added to 3 mL liquid LB
medium that was inoculated with bacteria. All of the
tests were incubated at 200 rpm. E. coli was cultured
at 37 °C for 2 d, whereas other bacteria were cul-
tured at 30 °C for 2 d. The lowest concentration
without turbidity was defined as the minimum in-
hibitory concentration (MIC) of that substance. The
medium without turbidity (50 μL) was inoculated
with 3 mL of fresh LB liquid medium, and cultured
in a shaker. E. coli was cultured at 37 °C for 2 d,
and all other bacteria were cultured at 30 °C for 2 d.
The lowest concentration without turbidity was
defined as the minimum bactericidal concentration
(MBC) of that substance. Same concentration of
DMSO without GA and salicylic acid was added in
control groups.
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Measurement of fluorescence decay of GFP in bacteria
Single colonies of E. coli DH5α-gfp, P. Putida KT2440-
gfp and B. amyloliquefaciens SQR9-gfp were extracted
from solid LB plates, inoculated in liquid LB medium,
and then 50 μg mL−1 Amp, Gm and Km was added to
the medium to maintain the normal replication of plasmids
in each strain. The medium was then centrifuged, and the
bacteria were collected. The supernatant was discarded,
and phosphate buffer was added to the collected bacteria to
obtain the bacteria concentration of 108 CFU mL−1. GA
was then dissolved in DMSO to prepare stocks with
different concentrations.
(1) 10 μL of GA stock solution at different concentrations
was added to 1 mL of bacteria solution. The final
concentrations of GA in the solution were 500 μg mL
−1, 250 μg mL−1, 100 μg mL−1, 50 μg mL−1, 25 μg mL
−1, 10 μg mL−1 and 5 μg mL−1, respectively. 10 μL of
DMSO without the drug was used as a control. All of
the tests were incubated at 30 °C for 1 min before GFP
fluorescence was measured. The morphology of the
bacteria was monitored under a scanning electron
microscopy. For strains of E. coli DH5α-gfp and P.
Putida KT2440-gfp, the incubation was extended to
4 h and additional samples were collected to measure
GFP fluorescence. The morphology of the bacteria was
measured using a scanning electron microscopy. Bac-
teria GFP fluorescence was initially observed by the
naked eye using an LB16 Maestrogen UltraSlim no-
damage blue LED transilluminator. Measurements of
bacterial GFP fluorescence were performed using a
Spectra ax M5 multifunctional microplate reader.
The samples’ fluorescence intensity was measured
when the excitation wavelength was 488 nm and
the emission wavelength was 509 nm. The blank
was the E. coli bacteria solution without GFP.
(2) 1 mL of bacteria solution was lysed by sonication.
The broken bacteria were centrifuged at 12,000 × g,
4 °C for 20 min, and then the supernatant was
collected. GA stock solution was added to the
supernatant. The final concentrations of GA in the
bacteria solution were 500 μg mL−1, 250 μg mL−1,
100 μg mL−1, 50 μg mL−1, 25 μg mL−1, 10 μg mL−1
and 5 μg mL−1, respectively. 10 μL of DMSO
(without the drug) was used as a control. All of the
tests were incubated at 30 °C for 1 min before GFP
fluorescence was measured. The control was the
crude enzyme solution of the corresponding bacteria
without GFP.
Effect of GA on the activities of a variety of proteins
Effect of GA on the activity of Taq DNA polymerase
Stock solutions at different concentrations were prepared
by dissolving GA in DMSO. GA stock solutions (0.5 μL)
at different concentrations were then added into each
PCR reaction system. The final concentrations of GA in
the reaction system were 25 μg mL−1, 10 μg mL−1,
5 μg mL−1 and 1 μg mL−1, respectively. 0.5 μL of DMSO
(without the drug) was as a control. The PCR reaction
conditions were adopted the reference of Chester and
Marshak [36]. After the reaction was finished, 3 μL of
PCR product was analyzed on an appropriate agarose gel.
GelRed nucleic acid dye was used to stain the gel.
Effect of GA on the activity of restriction enzymes
Three common restriction enzymes (Kpn I, Hind III
and EcoR I) were selected as the targets. GA was
dissolved in DMSO to prepare stock solutions with
different concentrations. A single colony of E. coli that
carried the pUC19 plasmid, was extracted and inocu-
lated in 3 mL of LB medium containing Amp, which
was then cultured at 37 °C overnight with vigorous
shaking. 41.5 μL of pUC19 (200 ng μg−1), 5 μL of 10 ×
restriction enzyme buffer, 3 μL of corresponding re-
striction enzyme, and 0.5 μL of GA stock solution with
different concentrations were mixed. The final con-
centrations of GA in the reaction system were
25 μg mL−1, 10 μg mL−1, 5 μg mL−1 and 1 μg mL−1, re-
spectively. 5 μL of DMSO (without the drug) was used
as a control. All of the components in the reaction
systems were digested at 37 °C for 4 h, and then the
temperature was increased to 75 °C for 15 min to stop
the enzyme digestion. Electrophoresis was then carried
out to examine the enzyme digestion.
Effect of GA on the activity of superoxide dismutase
According to the method by Beauchamp et al. [37], GA
was dissolved in DMSO to prepare stock solutions with
different concentrations. 80 μmol L -1riboflavin,
77 μmol L -1 nitro blue tetrazolium (NBT), 13 mmol L−1
methionine, 0.1 mmol L−1 EDTA, 20 μL superoxide dis-
mutase (SOD) enzyme solution (1 μg mL−1), and 5 μL of
the different concentrations of GA stock solution (final
concentrations of GA in the reaction system of
25 μg mL−1, 10 μg mL−1, 5 μg mL−1 and 1 μg mL−1)
were mixed. 5 μL of DMSO (without the drug) was used
as a control. After the samples were exposed to light at
4500 Lux light intensity for 15 min, the reaction was
stopped by shielding the light. The optical density
(OD)560 values were measured. One active unit (U)
occurred when NBT was inhibited by 50%, and enzyme
activity = (△ A ×N × 60)/(W × T × V × 50%), where △ A
represented the difference in OD values between the
control and sample, N represented the total volume of
enzyme solution, W represented the protein mass, T
represented the light reaction time and V represented
the volume of enzyme solution added. Enzyme activity
was represented as OD560 • mg
−1 (pro) • min−1.
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Effect of GA on the activity of β-galactosidase
2 μg mL−1 the enzyme β-galactosidase was prepared in
10 mM pH 7.0 phosphate buffer. GA was dissolved in
DMSO to prepare the stock solutions with different con-
centrations. Enzyme solution (1 mL) was incubated at
37 °C for 5 min, then 1 mL of phosphate buffer (pH 7.0)
containing 20 mM ONPG preheated to 37 °C was added,
finally 5 μL of the different concentrations of GA stock
solution were added. The final concentrations of GA in
the reaction system were 25 μg mL−1, 10 μg mL−1,
5 μg mL−1 and 1 μg mL−1, respectively. 5 μL of DMSO
(without the drug) was used as a control. All of the sam-
ples were incubated in a 37 °C for 10 min, and then
3 mL of 0.5 mol L−1 Na2CO3 was added to stop the re-
action. The OD value at 420 nm was read. One enzyme
unit was defined as the amount of enzyme required to
release 1 μmol of ONP per minute at 37 °C.
Inhibition of isotopic precursor incorporation
According to the method by Aspedon and Groisman
[21], [3H] TdR, [3H] UR and [3H] Tyr were incorpo-
rated into precursors to investigate effect of GA
(C15:1) on the biosynthesis of DNA, RNA and B.
amyloliquefaciens SQR9 protein. The logarithmic
growth phase SQR9 culture was diluted with sterile
water. In a 96-well plate, 0.9 mL of bacterial suspension
(OD600 = 0.1) was added to each well. The isotope-labeled
precursor (final concentration was 0.5 μCi mL−1) and 5 μL
of the different concentration of GA (C15: 1) were also
added into the well. The final concentrations of GA in the
reaction system were 25 μg mL−1, 10 μg mL−1 and
5 μg mL−1, respectively. 5 μL of DMSO (without the drug)
was used as a control. All of the treatments were
conducted at 37 °C in a shaker. When examining
effect of GA (C15:1) on the synthesis of DNA and
RNA, culture time for bacteria was limited to one
generation. After growing the culture for 30 min, the
culture was centrifuged at 12,000 × g, 4 °C for 5 min
to harvest the bacteria pellet. Because protein syn-
thesis was relatively slow, the bacteria culture time
was extended to 2 h. OD600 was also adjusted so
that the cultures had the same bacteria concentra-
tion. The bacteria pellet was washed three times
with phosphate buffer and then placed in an oven
overnight to dry it. Scintillation solution was directly
added to the Eppendorf tubes containing bacteria,
and the tubes were then transferred to a scintillation
counter (LS3801, Beckman) to determine the counts
per minute (CPM) values. The average CPM values
of the experimental group and control group were
compared. The incorporation inhibition rate was
calculated. Incorporation inhibition rate = control
group CPM - experimental group CPM/control group
CPM× 100%.
Effect of GA (C15:1) on GFP fluorescence in the
protoplasts of E. coli
E. coli protoplasts were prepared according to the
method described by Weiss [38]. GA was dissolved in
DMSO, and its stock solutions with different concentra-
tions were prepared. E. coli protoplasts (1 mL) were
diluted with sucrose-magnesium-maleate (SMM) buffer
(protoplast number > 107 CFU mL−1), and 5 μL of the
different concentration GA stock solutions were added.
The final concentrations of GA in the reaction system
were 500 μg mL−1, 250 μg mL−1, 100 μg mL−1,
50 μg mL−1, 25 μg mL−1, 10 μg mL−1 and 5 μg mL−1, re-
spectively. 5 μL of DMSO (without the drug) was used
as a control. All the tests were incubated at 30 °C for
1 min, and then the samples were analyzed for GFP
fluorescence. GFP fluorescence was initially observed by
the naked eye using an LB-16 Maestrogen UltraSlim no-
damage blue LED transilluminator. GFP fluorescence
was measured with a Spectra ax M5 multifunctional
microplate reader. The samples’ fluorescence intensity
was measured when the excitation wavelength was
488 nm and the emission wavelength was 509 nm. The
blank was E. coli protoplast solution without GFP.
The interception of GA by the lipid-soluble component in
E. coli cell walls
E. coli DH5α-gfp was cultured in 100 mL of liquid LB
medium at 37 °C, 200 rpm overnight. After centrifuga-
tion at 12,000 × g for 5 min, the supernatant was
discarded to collect the bacteria. The bacteria pellet was
then re-suspended in the same volume of phosphate
buffer. The half was retained for the experiments and
the left half was centrifuged at 12,000 × g for 5 min. The
supernatant was then discarded. A small volume of
phosphate buffer was used to re-suspend the bacteria
pellet, and then 10 mL of 70% ethanol solution was
added, mixed well, and kept at room temperature for
30 s before centrifuging at 12,000 × g for 1 min. The
supernatant ethanol solution was then discarded. Phos-
phate buffer (50 mL) was used to re-suspend the
bacteria pellet, which was centrifuged at 12,000 × g for
5 min. The supernatant was then discarded. Finally,
50 mL of phosphate buffer was used to re-suspend the
bacteria pellet for the experiments.
GA was dissolved in DMSO, and its stock solutions
with different concentrations were prepared. GA stock
solutions (5 μL) at different concentrations were added
to 1 mL of bacteria solution before/after ethanol
solubilization of the lipids. The final concentrations of
GA in the reaction system were 500 μg mL−1,
250 μg mL−1, 100 μg mL−1, 50 μg mL−1, 25 μg mL−1,
10 μg mL−1 and 5 μg mL−1, respectively. 5 μL of DMSO
(without the drug) was used as a control. All the tests
were incubated at 30 °C for 1 min, and then the samples
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were examined for GFP fluorescence. GFP fluorescence
was initially observed by the naked eye using an LB-16
Maestrogen UltraSlim no-damage blue LED transillumi-
nator. GFP fluorescence was measured using a Spectra
ax M5 multifunctional microplate reader. The samples’
fluorescence intensity was measured when the excitation
wavelength was 488 nm and the emission wavelength
was 509 nm. The blank was E. coli bacteria solution
without GFP (after ethanol solubilization).
Statistical analyses
For all the experiments throughout the study, we collected
three individual tubes from LB plates, and each tube was
performed in triplicate. In analysis, comparisons were
carried out using the fluorescent means of each triplicate,
then, finally each bar in the gram represents means of
three individual tubes. The data of each strain was
analyzed using one-way ANOVA (i.e., B. amyloliquefaciens
SQR9-gfp E. coli DH5α-gfp and P. putida KT2440-gfp),
with final concentration of GA as the fixed factors (P <
0.05). The experimental data were log transformed to
meet the homogeneity of variance or a normal distribu-
tion of residuals. All statistical analyses were conducted
using SPSS 13.0 (SPSS, Chicago, IL, USA).
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